-
-
Recent Posts
- Coronavirus today and the SCI community tomorrow
- Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Category Archives: Ligand
The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
Author: James W. Fawcett Abstract: Axon regeneration in the CNS is inhibited by many extrinsic and intrinsic factors. Because these act in parallel, no single intervention has been sufficient to enable full regeneration of damaged axons in the adult mammalian … Continue reading
Posted in Chronic Spinal Cord Injury Research, Gene Therapy, Ligand, spinal cord injury research, Stem Cell Research
Tagged Dr. James Fawcett
Comments Off on The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
NERVGEN PHARMA COMPLETES $10 MILLION INITIAL PUBLIC OFFERING
Vancouver, Canada. March 13, 2019 – NervGen Pharma Corp. (“NervGen” or the “Company”), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage, today announced that it has completed its initial public offering (“IPO”) of … Continue reading
Posted in Ligand, Regenerative Medicine, spinal cord injury research
Tagged Case Western Reserve University, Dr. Jerry Silver, NervGen Pharma Corp
Comments Off on NERVGEN PHARMA COMPLETES $10 MILLION INITIAL PUBLIC OFFERING
Dr Jerry Silver – Spinal Cord Damage and Emerging Treatments
“Injuries to the spinal cord can cause permanent paralysis and even lead to death, with little to no hope of regaining lost functions once the trauma has occurred. Dr Jerry Silver and his team at Case Western Reserve University Medical … Continue reading
Posted in Chronic Spinal Cord Injury Research, Ligand, Regenerative Medicine, spinal cord injury research
Tagged Case Westerm Reserve University, Dr. Jerry Silver, NervGen Pharma Corp
Comments Off on Dr Jerry Silver – Spinal Cord Damage and Emerging Treatments
SPINAL CORD INJURY RESEARCH AND SCIENCE 